Skip to main content
. 2016 Oct 28;17(11):1808. doi: 10.3390/ijms17111808

Figure 4.

Figure 4

Survival value validation of patients with grades III and IV gliomas by the three-gene signature. (A,B) The three-gene signature classified patients into low mRNA and high mRNA expression groups which differed in overall survival and grade III of GSE4412 dataset significantly; (C) The three-gene signature significantly separated patients in IV (GBM) into high and low expression groups in TCGA dataset. The p-values were computed by the log-rank test.